{"id":632865,"date":"2025-07-15T16:46:30","date_gmt":"2025-07-15T20:46:30","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=632865"},"modified":"2025-07-15T16:46:30","modified_gmt":"2025-07-15T20:46:30","slug":"mounjaro-side-effects-in-females","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/mounjaro-side-effects-in-females\/","title":{"rendered":"Mounjaro side effects in females: What women should know"},"content":{"rendered":"

Mounjaro<\/span><\/a> (tirzepatide) is a prescription drug approved by the Food and Drug Administration (FDA) to treat <\/span>Type 2 diabetes<\/span><\/a>. However, because it suppresses appetite, Mounjaro is sometimes prescribed off-label for weight loss. As diabetes medications and weight loss medications like <\/span>Ozempic<\/span><\/a>, <\/span>Wegovy<\/span><\/a>, and <\/span>Mounjaro<\/span><\/a> have become more popular, many women have expressed concern about the possibility of female-specific side effects. At this time, there are no studies focused solely on female Mounjaro users, and because these are new medications, the long-term side effects are also unknown. Still, female Mounjaro users need to know that weight loss can impact the menstrual cycle, which affects <\/span>fertility<\/span><\/a>.<\/span><\/p>\n

How Mounjaro works<\/span><\/h2>\n

Mounjaro<\/span><\/a> is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (<\/span>GLP-1<\/span><\/a>) receptor agonist. According to<\/span> Eli Lilly<\/span><\/a>, the drug\u2019s manufacturer, it works by activating the body\u2019s GIP and GLP-1 receptors, stimulating insulin production to improve glucose control and curb cravings.\u00a0<\/span><\/p>\n

For people with <\/span>Type 2 diabetes<\/span><\/a>, this results in healthier <\/span>blood sugar levels<\/span><\/a> and, in many cases, a healthier body weight. Mounjaro\u2019s effects on appetite are the reason it is also sometimes prescribed off-label for weight loss. However, tirzepatide, the active ingredient in Mounjaro, is also sold under the brand name <\/span>Zepbound<\/span><\/a>, which is FDA approved for <\/span>weight management<\/span><\/a> in adults with <\/span>obesity<\/span><\/a> or who are overweight with a weight-related health condition. Zepbound is also <\/span>approved for obstructive sleep apnea<\/span><\/a>.<\/span><\/p>\n

RELATED: <\/span>Zepbound vs. Mounjaro<\/span><\/a><\/p>\n

Common side effects of Mounjaro\u00a0<\/span><\/h2>\n

In clinical trials, these were the most <\/span>common side effects of Mounjaro<\/span><\/a>:<\/span><\/p>\n